| Business Summary | | Healthcare
Technologies
(HCT),
an
Israeli
company
established
in
1988,
specializes
in
the
development,
manufacture
and
marketing
of
clinical
diagnostic
test
kits,
and
provides
services
and
tools
to
diagnostic
and
biotech
research
professionals
in
laboratory
and
point
of
care
sites
worldwide,
through
its
affiliated
companies
Savyon
Diagnostics
Ltd.
(Savyon),
Gamidor
Ltd.,
Gamidor
Diagnostics
Ltd.
and
Danyel
Biotech
Ltd.
HCT
is
committed
to
supplying
its
customers
throughout
the
world
with
products
of
high
quality,
supported
by
intensive
research
and
development
programs,
rigorous
quality
control
procedures,
and
dedicated
technical
and
customer
service
teams.
The
Company's
major
shareholder
is
the
Netherlands-based
Gamida
for
Life
Group,
which
itself
is
engaged
internationally
in
the
research,
development,
production
marketing
and
sales
of
products
and
services
for
the
healthcare
and
the
scientific
community. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Healthcare
Technologies
is
an
Israeli
based
company
operating
worldwide
in
vitro
diagnostic
and
biotech
markets
in
the
areas
of
product
development,
manufacturing
and
distribution.
For
the
six
months
ended
6/30/01,
revenues
rose
13%
to
$8.5
million.
Net
loss
rose
48%
to
$825
thousand.
Revenues
reflect
increased
marketing
efforts
and
the
Group's
recent
business
development,
related
to
its
Gamidor
and
GamidaGen
subsidiary.
Net
Loss
reflects
lower
gross
profit
margin. | More
from
Market Guide: Significant
Developments |
| Officers | |
| Position | Daniel Kropf | Chairman,
CEO |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|